About: MAPRx

Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Congressional leadership urging them to take action to address the looming increase in out-of-pocket (OOP) costs Medicare Part D beneficiaries will incur this year. This increase, known as the "OOP Cliff," is due to the OOP...

Earlier today, the MAPRx Coalition submitted feedback and comments on Title III of H.R. 3, the Lower Drug Costs Now Act of 2019, to the Chairs and Ranking Members of the House of Representatives' Ways & Means, Energy & Commerce, and Education & Labor Committees. The Coalition appreciates the House's leadership in advancing policy to cap out-of-pocket...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2019 – December 7, 2019 for coverage beginning January 1, 2020. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole may also...

Today, the MAPRx Coalition and 28 of its members, national organizations representing patients, caregivers, and healthcare professionals, submitted a letter to the Senate Finance Committee on their recently released legislation, The 2019 Prescription Drug Pricing Reduction Act of 2019. The Coalition greatly appreciates the Committee's leadership in improving access to prescription drugs for the more than 44...

On June 6, MAPRx and 45 national advocacy organizations submitted a letter to leadership in the House of Representatives' Ways and Means Committee and Energy and Commerce Committee with recommendations for improving Medicare Part D. Among other improvements, the letter made clear that the MAPRx Coalition supports a cap on out-of-pocket spending for the more...

Today MAPRx submitted comments on behalf of the Coalition and 23 member organizations in support of the Department of Health and Human Services’ proposed rule to reform the rebate system in Medicare Part D in an effort to lower out-of-pocket costs for Part D beneficiaries. The Coalition has long recognized that for the more than 43...

32 MAPRx Members Urge CMS to Take Care in Reforming Critical Prescription Drug Benefit Today MAPRx submitted comments on behalf of the Coalition and 32 member organizations to the Centers for Medicare and Medicaid Services' (CMS) proposed rule entitled Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses which...

Study Finds Popular Prescription Drug Benefit Program Poses Significant Challenges to Beneficiaries

A new report released today on Medicare Part D found the program is as popular and robust as ever, but poses significant challenges to beneficiaries that result in increased out-of-pocket costs and limited access for millions of beneficiaries. The study, “ Read more

In an op-ed published in The Hill on October 10, Carl Schmid, deputy executive director of MAPRx member organization The AIDS Institute, wrote about the challenges and opportunities facing Medicare Part D. While highlighting the popularity of the prescription drug benefit with nearly 44 million enrolled beneficiaries, Carl also notes that out-of-pocket costs...

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2018 - December 7, 2018 for coverage beginning January 1, 2019. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. In 2019, the Part D coverage gap (“donut hole”)...